ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

TENX Tenax Therapeutics Inc

3.80
0.01 (0.26%)
시간외 거래
최종 업데이트: 07:30:10
15분 지연
기업명 주식 심볼 시장 주식 타입
Tenax Therapeutics Inc TENX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.01 0.26% 3.80 07:30:10
개장가 저가 고가 종가 전일 종가
3.83 3.78 3.86 3.84 3.79
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202420:30GLOBETenax Therapeutics Announces New U.S. Patent Covering the..
09/04/202421:30GLOBETenax Therapeutics to Host KOL Event: “LEVEL Setting: the..
28/03/202421:30GLOBETenax Therapeutics Provides Business and Clinical..
12/03/202421:30GLOBETenax Therapeutics to Present at the 36th Annual Roth..
29/02/202423:00GLOBETenax Therapeutics Announces Oral Presentation of..
27/02/202406:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/02/202406:30EDGAR2Form 8-K - Current report
21/02/202406:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/02/202422:33EDGAR2Form 8-K - Current report
20/02/202422:30GLOBETenax Therapeutics Announces Global License Amendment that..
17/02/202401:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/02/202409:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202406:46EDGAR2Form 8-K - Current report
08/02/202422:16GLOBETenax Therapeutics Announces Pricing of Approximately $9..
08/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
08/02/202410:01GLOBETenax Therapeutics Enrolls First Patient in Phase 3 LEVEL..
06/02/202422:56EDGAR2Form 8-K - Current report
06/02/202422:30GLOBETenax Therapeutics Announces USPTO Grants Notice of..
03/02/202407:24EDGAR2Form S-1/A - General form for registration of securities..
02/02/202406:20EDGAR2Form S-1/A - General form for registration of securities..
20/01/202406:30EDGAR2Form 8-K - Current report
13/01/202407:46EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/01/202406:30EDGAR2Form 8-K - Current report
06/01/202406:46EDGAR2Form 8-K - Current report
02/12/202306:47EDGAR2Form S-1 - General form for registration of securities under..
02/12/202306:01EDGAR2Form 8-K - Current report
17/11/202322:30GLOBETenax Therapeutics Announces Professor Javed Butler, M.D.,..
15/11/202306:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:10EDGAR2Form 8-K - Current report
13/11/202322:30GLOBETenax Therapeutics Announces FDA Clearance of IND for..
30/09/202305:11EDGAR2Form 8-K - Current report
16/08/202305:05EDGAR2Form 8-K - Current report
15/08/202305:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/07/202305:30EDGAR2Form 8-K - Current report
19/07/202321:30GLOBETenax Therapeutics Issued U.S. Patent for Oral Levosimendan..

최근 히스토리

Delayed Upgrade Clock